Harvard Health Letter

New concerns about anticholinergic medications

Anticholinergic use among older adults for three or more years is linked to an increased risk for developing dementia and Alzheimer's disease.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In